Latest filing published 12 Dec 2018 for Amphastar Pharmaceuticals, Inc., €753k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +36.9%Entry US$10.07 · Close at T+365 US$13.79
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Stephen B. Shohet: trading record in brief
Stephen B. Shohet appears in our data through filings on Amphastar Pharmaceuticals, Inc. shares, published by SEC (Form 4). We count 42 filings; the first trade dates from 15 August 2014 and the latest from 10 December 2018.
Both buying and selling appear: 1 purchase worth €27k, against 19 sales worth €3.7M. Netting one side against the other leaves €3.6M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants and 18 option exercises. 2018 to date brings no purchases and 1 sale.
On 12 December 2018 came the latest disclosure, an open-market sale for €1.1M in Amphastar Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 4,465 days ago, on 19 August 2014. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Stephen B. Shohet
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 58,557 shares@ US$14.6640.3% of flowCommon StockSEC:0001104659-18-072625:0
- 58,557 shares@ US$21.7259.7% of flowCommon StockSEC:0001104659-18-072625:1
- 6,590 shares0Common StockSEC:0001104659-18-039452:0
- 7,866 shares@ US$10.771.4% of flowCommon StockSEC:0001104659-17-073458:0
- 7,866 shares@ US$18.872.4% of flowCommon StockSEC:0001104659-17-073458:1
- 7,862 shares@ US$10.771.4% of flowCommon StockSEC:0001104659-17-072538:0
- 7,862 shares@ US$18.342.3% of flowCommon StockSEC:0001104659-17-072538:1
- 7,862 shares@ US$10.771.4% of flowCommon StockSEC:0001104659-17-071206:0
- 7,862 shares@ US$19.252.4% of flowCommon StockSEC:0001104659-17-071206:1
- 7,862 shares@ US$10.771.4% of flowCommon StockSEC:0001104659-17-070338:0
- 7,862 shares@ US$18.942.4% of flowCommon StockSEC:0001104659-17-070338:1
- 7,862 shares@ US$10.771.4% of flowCommon StockSEC:0001104659-17-069497:0
- 7,862 shares@ US$18.042.3% of flowCommon StockSEC:0001104659-17-069497:1
- 7,862 shares@ US$10.771.4% of flowCommon StockSEC:0001104659-17-067523:0
- 800 shares@ US$17.510.2% of flowCommon StockSEC:0001104659-17-067523:1
- 6,962 shares@ US$18.662.1% of flowCommon StockSEC:0001104659-17-067523:2
- 100 shares@ US$19.060.0% of flowCommon StockSEC:0001104659-17-067523:3
- 7,862 shares@ US$10.771.4% of flowCommon StockSEC:0001104659-17-066033:0
- 7,862 shares@ US$18.372.4% of flowCommon StockSEC:0001104659-17-066033:1
- 7,862 shares@ US$10.771.4% of flowCommon StockSEC:0001104659-17-064081:0
- 7,862 shares@ US$18.392.4% of flowCommon StockSEC:0001104659-17-064081:1
- 7,862 shares@ US$10.771.4% of flowCommon StockSEC:0001104659-17-063007:0
- 7,862 shares@ US$18.342.3% of flowCommon StockSEC:0001104659-17-063007:1
- 7,862 shares@ US$10.771.4% of flowCommon StockSEC:0001104659-17-062197:0
- 7,862 shares@ US$18.732.4% of flowCommon StockSEC:0001104659-17-062197:1
25 of 40 declarations
